Vectura Group (VEC)

 

VEC Share PerformanceMore

52 week high176.20 03/05/16
52 week low122.90 30/08/16
52 week change -34.50 (-19.65%)
4 week volume38,903,530 02/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - RBC Capital Markets issues a broker note on Vectura Group PLC

RBC Capital Markets today downgrades its investment rating on Vectura Group PLC (LON:VEC) to underperform (from...

Report and Accounts ended 31 Dec 2016 and AGM 2017

RNS Number: 1287D Vectura Group plc 24 April 2017 Vectura Group plc Report and Accounts for the nine-month period ended 31 December 2016 and Annual General Meeting 2017 Vectura Group plc (LSE: VEC) ("Vectura", "the Company") announces that today it has released the following documents: Report and Accounts for the nine-month period ended 31 Dece...

Broker Forecast - N+1 Singer issues a broker note on Vectura Group PLC

N+1 Singer today downgrades its investment rating on Vectura Group PLC (LON:VEC) to sell (from buy) and cut its price...

Vectura looks to change auditor

Vectura Group has announced that, following the successful conclusion of a tender process, a proposal will be put to share...

External audit tender process concluded

RNS Number: 7233C Vectura Group plc 19 April 2017 Vectura Group plc External audit tender process successfully concluded Chippenham, UK - 19 April 2017: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading device and formulation business for inhaled airways products, announces the successful conclusion of a tender process for the provision of its ...

Holdings in Company

RNS Number: 1957C Vectura Group plc 11 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Vectura Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisitio...

Director/PDMR Shareholding

RNS Number: 9717B Vectura Group plc 07 April 2017 VECTURA GROUP PLC DIRECTOR/PDMR SHARE DEALING Vectura Group plc 7 April 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them Vectura Group plc (LSE: VEC; "Vectura" or "the Company") confirms...

Vectura benefits from Breelib launch in Poland

Vectura has confirmed that its partner Bayer has launched Breelib, the new nebuliser for Ventavis, in Poland. Breelib has...

Fundamental DataMore

P/E ratio117.583
EPS1.2
Dividend yield0 %

Latest discussion posts More

  • Re: Price has fallon news that got advai...

    d297 - well, optimism is looking a tad wobbly today, and IF ONLY FDA approval was guaranteed! Unfortunatly its not, but Bios are exciting and risky, and we are hopefully all ...
    25-Apr-2017
    Andy Reilly
  • Re: Price has fallon news that got advair FD...

    Hopefully our product will be approved & come under the category of "bigger threat ". Sunny day in & have to remain optimistic !!
    25-Apr-2017
    dave297
  • Price fall. Teva have gained first FDA on Advair ...

    This is why our price fell today, it appears Teva received FDA clearance for their own generic Advair, however, it doesn?t work in the same way as Advair does ,nor can it be ...
    24-Apr-2017
    d gaser

Users' HoldingsMore

Users who hold Vectura Group also hold..
LLOYDS GRP.30%
VODAFONE GRP.23%
BP21%
AVIVA17%
BARCLAYS17%

Codes & Symbols

ISINGB00B01D1K48
SymbolsVEC, LSE:VEC, VEC.L, VEC:LN, LON:VEC, XLON:VEC